$55.26
0.6%
Price vs. AI Score (Last 150 days)
Data gathered: December 11
Data gathered: December 11
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 715 -0.3% |
|
| Sentiment | 75 0% |
|
| Webpage traffic | 774,000 13.7% |
|
| Employee Rating | 83 0% |
|
| Google Adspend | $26,092 -31.4% |
|
| Google Trends | 23 -68.9% |
|
| Linkedin Employees | 43,061 N/A |
|
| Lobbying Cost | $127,000 0% |
|
| NPS | 15 -16.7% |
|
| Patents | 3,732 0% |
|
| 4chan Mentions | 0% |
|
| Facebook Engagement | 356 -25.8% |
|
| Facebook followers | 70,446 0% |
|
| Stocktwits Mentions | 2 -33.3% |
|
| Stocktwits Subscribers | 5,450 0% |
|
| Twitter Followers | 40,090 0% |
|
| News Mentions | -100% |
|
| Reddit Mentions | 0% |
|
| ESG | 80 1.3% |
|
| Business outlook | 78 0% |
|
In the news
 |
Experts in concussion, NFL leaders gather to identify gaps in knowledge, offer guidelines on preventing brain injuries | CNNDecember 8 - CNN |
 |
Climate, health, and the Rising Tide #ClimateCrisis #Metacrisis #Overshoot Pearls and IrritationsDecember 8 - Wordpress.com |
 |
Boston Scientific Corp. stock underperforms Friday when compared to competitorsDecember 8 - MarketWatch |
TILT Biotherapeutics Announces Positive Clinical Data in Checkpoint Resistant Metastatic Melanoma Phase I Trial at ESMO Immuno-Oncology 2023December 8 - GlobeNewswire |
|
 |
Fentanyl, fenlands, and Boris Johnson's COVID defenceDecember 7 - The Naked Scientists |
 |
Here's Why You Should Retain Boston Scientific (BSX) NowDecember 7 - Yahoo |
About Boston Scientific
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
| Price | $55.26 |
| Target Price | Sign up |
| Market Cap | $80.5B |
| Dividend Yield | 0.0194 |
| Industry | Medical Devices |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 3.46B | 2.58B | 2.43B | 504M | 883M |
| Q2 '23 | 3.53B | 2.71B | 2.54B | 270M | 706M |
| Q1 '23 | 3.32B | 2.49B | 2.35B | 314M | 713M |
| Q4 '22 | 194M | 2.39B | 2.23B | 194M | 712M |
| Q3 '22 | 3.3B | 2.45B | 2.19B | 188M | 510M |
Insider Transactions
| Mirviss Jeffrey B. filed to sell 56,588 shares at $55. December 7 '23 |
| Butcher Arthur C filed to sell 6,977 shares at $54.1. November 21 '23 |
| Carruthers Wendy filed to sell 46,532 shares at $54.2. November 16 '23 |
| Mahoney Michael F filed to sell 1,498,922 shares at $52.5. November 7 '23 |
| Carruthers Wendy filed to sell 51,795 shares at $49.8. October 17 '23 |
Read more about Boston Scientific and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, lobbying cost, nps, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, reddit mentions, esg, business outlook.